Taking phototherapeutics from concept to clinical launch
Brianna M Vickerman1, Emilia M Zywot2, Teresa K Tarrant3
1Department of Chemistry, University of North Carolina, Chapel Hill, NC, USA.
Nature Reviews. Chemistry
|April 28, 2023
Summary
Light-activated drugs offer precise control for treating diseases. Recent advances focus on photoresponsive compounds that penetrate tissues, moving closer to clinical use.
Area of Science:
- Photomedicine
- Drug Delivery
- Biotechnology
Background:
- Light-activated (caged) compounds offer spatial and temporal control over biological processes.
- Their application in drug delivery and activation has been limited by light penetration issues.
- Recent development of photoresponsive drugs in the optical window of tissue (600-900 nm) addresses these limitations.
Purpose of the Study:
- To review recent discoveries in phototherapeutics responsive to near-infrared light.
- To discuss the limitations and clinical opportunities of these emerging light-activated drugs.
- To highlight the path toward clinical translation of phototherapeutics.
Main Methods:
- Literature review of recent advancements in light-activated drug research.
- Analysis of studies focusing on tissue penetrance and wavelength dependency.
- Discussion of preliminary in vivo studies and potential disease applications.
Main Results:
- Several novel phototherapeutics operating within the optical window of tissue have been developed.
- Preliminary in vivo studies show promise but highlight challenges for clinical translation.
- The wavelength-dependent nature of light penetration remains a critical factor.
Conclusions:
- Phototherapeutics offer unique advantages for targeted drug delivery and activation.
- Further research and development are needed to overcome limitations in tissue penetration and in vivo efficacy.
- These light-activated drugs hold significant potential for various disease applications, pending successful clinical translation.
Related Concept Videos
Clinical Trials: Overview
3.1K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.1K
Preclinical Development: Overview
4.5K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.5K
Clinical Trials
6.9K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.9K
Drug Administration and Therapy Phases: Overview
592
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
592
Clinical Applications of Epidermal Stem Cells
2.7K
Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
2.7K
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K


